Reuters logo
BRIEF-Trovagene Inc announces deal with Nerpharma
2017年6月29日 / 中午12点27分 / 5 个月前

BRIEF-Trovagene Inc announces deal with Nerpharma

June 29 (Reuters) - Trovagene Inc:

* Trovagene announces manufacturing agreement with Nerpharma for supply of PCM-075 for AML trial

* Trovagene - agreement covers clinical, commercial supply of PCM-075 for co, includes both active pharmaceutical ingredients, GMP production of capsules

* Trovagene Inc - plans to initiate a phase 1B/2 clinical trial in patients with acute myeloid leukemia (AML) Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below